Navigation Links
CBLPath Opens Manhattan Facility

New location brings laboratory services closer to Metropolitan area physicians

Rye Brook, N.Y. (PRWEB) May 28, 2009 -- CBLPath, Inc., one of the nation's fastest-growing providers of specialized anatomic pathology services, today announced the opening of its Manhattan Facility as part of the company's continuous effort to enhance services for Metropolitan area physicians. Licensed by the New York State Department of Health (NYSDOH), the new facility is located at 400 East 66th Street, Suite 2D, and augments CBLPath's state-of-the-industry 66,000-square-foot main laboratory facility, which is located at 760 Westchester Avenue in Rye Brook, N.Y.

"We're very pleased to be able to bring our laboratory services closer to our physician-clients' practices," said Madeline Vazquez, M.D., Associate Director of the Manhattan Facility.

To find out more about the CBLPath Manhattan Facility, contact the company's Client Services Department or your local sales and service representative at 877.CBLPath (877.225.7284).

CBLPath, Inc. is a landmark anatomic pathology laboratory that delivers state-of-the-industry diagnostic testing and innovative technology solutions to its physician-clients across the nation. Founded in 1988 as Cytopath Biopsy Lab, CBLPath quickly established a reputation for providing timely and highly accurate diagnoses along with extraordinary customer service and a true patient-centered commitment. Additional information about the company is available by visiting

This news release may contain forward-looking statements (as delineated in the Private Securities Litigation Reform Act of 1995), which are based on the expectations, projections and beliefs of company management at the time of pronouncement. Some forward-looking statements may be identified by the use of such terms as "believes," "anticipates," "may," "intends," "plans," "estimates," "projects" and "expects." The company takes no obligation to update or revise any such statements after the date on which they are made. Forward-looking statements are subject to a wide range of risks and uncertainties that can cause actual results to differ materially from anticipated results. These variable factors include, but are not limited to, operating initiatives and acquisitions, general economic conditions, the competitive environment, federal and state laws and regulations (and changing interpretations thereof), reimbursement rates under government and third party healthcare programs and unanticipated expenditures. Accordingly, no assurance can be given as to the future financial condition, cash flow or results of operations of the company or any of its businesses. Further information regarding factors that could cause the company's results to differ from expectations is included in its annual reports.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium
2. PRA International Opens Additional Drug Safety Center in Sao Paulo, Brazil
3. Alexian Brothers Medical Center Opens New Patient Tower
4. National Eyewear Chain Visionworks Opens Two New Stores in Orlando Market
5. National Eyewear Chain EyeMasters Opens Tenth Store in Cleveland Market
6. Law Offices of Bruce Egert Opens New Office in Hackensack
7. News media registration opens for ACS National Meeting in Washington, DC, Aug. 16-20
8. Medifast Weight Control Center Opens in Round Rock, TX
9. Research opens up new horizons to the design of customized medicines against breast cancer
10. As Kaiser Permanente Opens a New Hospital Wing, Security Officers Left Behind Without Affordable Healthcare
11. Hospital Opens New $19 Million Neonatal Intensive Care Unit
Post Your Comments:
Related Image:
CBLPath Opens Manhattan Facility
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: